What is the difference between clotting and clogging in dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clotting vs. Clogging in Dialysis: Key Differences and Clinical Implications

Clotting refers to thrombus formation within the dialysis circuit due to activation of the coagulation cascade, while clogging refers to mechanical obstruction of dialyzer fibers due to protein deposition, cellular debris, or other materials that reduce effective dialysis surface area without involving the coagulation system.

Clotting in Dialysis

Definition and Mechanism

  • Clotting involves the formation of blood clots (thrombi) through activation of the coagulation cascade when blood contacts the extracorporeal circuit 1
  • Occurs primarily due to contact activation of the coagulation system, inflammation, and platelet activation when blood passes through the dialysis circuit 2
  • Results in fibrin formation and platelet aggregation within the dialysis circuit

Clinical Presentation

  • Visible thrombus formation in the venous air trap (more common) or arterial air trap 3
  • Progressive darkening of dialyzer fibers
  • Decreased blood flow rates during dialysis
  • Complete thrombosis of the dialyzer membrane in severe cases
  • Typically occurs around 1.8 hours (±0.2) into dialysis treatment 3

Risk Factors

  • Inadequate anticoagulation during dialysis
  • Low blood flow rates (below 240 ml/min increases risk) 3
  • Shortened clotting time during dialysis
  • Inflammatory conditions
  • Hypercoagulable states
  • Oral anticoagulation alone (INR 2-3) is insufficient to prevent clotting 4

Prevention and Management

  • Standard anticoagulation with heparin (25-30 units/kg followed by 1,500-2,000 units/hour) 5
  • Low molecular weight heparin (LMWH) like dalteparin (40 IU/kg bolus) 4
  • Even patients on oral anticoagulants require additional heparin or LMWH during dialysis 4
  • Monitoring of activated partial thromboplastin time (APTT) 2

Clogging in Dialysis

Definition and Mechanism

  • Clogging involves mechanical obstruction of dialyzer fibers without activation of the coagulation cascade 1
  • Results from protein deposition, cellular debris, or other materials that reduce effective dialysis surface area
  • Occurs gradually over multiple uses of a dialyzer (in reuse settings)

Clinical Presentation

  • Progressive decrease in dialyzer efficiency without visible clotting
  • Reduced total cell volume (TCV) or fiber bundle volume
  • Decreased small-solute clearance
  • No visible thrombus formation in the circuit

Risk Factors

  • Inadequate rinsing of dialyzer during reprocessing
  • Multiple reuses of dialyzers
  • High-protein states
  • Inadequate dialyzer reprocessing related to poor quality control 1

Prevention and Management

  • Monitoring total cell volume (TCV) with each reuse 1
  • Ensuring TCV doesn't decrease by more than 20% (corresponds to 10% loss in clearance) 1
  • Proper rinsing procedures during reprocessing
  • Discarding dialyzers when TCV falls below 80% of original volume

Key Differences

  1. Pathophysiological mechanism:

    • Clotting: Activation of coagulation cascade and platelet aggregation
    • Clogging: Mechanical obstruction without coagulation activation
  2. Timing:

    • Clotting: Can occur acutely during a single dialysis session
    • Clogging: Typically develops gradually over multiple uses of a dialyzer
  3. Prevention:

    • Clotting: Requires anticoagulation (heparin, LMWH)
    • Clogging: Requires proper rinsing and reprocessing procedures
  4. Monitoring:

    • Clotting: Visual inspection of circuit, monitoring coagulation parameters
    • Clogging: Measurement of TCV, ionic clearance, or urea clearance 1
  5. Clinical impact:

    • Clotting: Can cause immediate session termination and blood loss
    • Clogging: Gradual decrease in dialysis efficiency over time

Clinical Implications

  • Both clotting and clogging can lead to inadequate dialysis, which increases morbidity and mortality 1
  • Early detection through proper monitoring is essential to prevent complications
  • Clotting requires immediate intervention, while clogging may be addressed during routine dialyzer reprocessing
  • Dialysis adequacy should be regularly assessed through Kt/V and URR measurements 1
  • Patients with recurrent clotting despite standard anticoagulation may require therapeutic anticoagulation 2

Common Pitfalls and Caveats

  • Don't confuse decreased dialyzer efficiency due to clogging with inadequate anticoagulation
  • Visual inspection alone may miss early clogging; regular monitoring of clearance parameters is essential
  • Increasing anticoagulation won't resolve clogging issues
  • Patients on oral anticoagulants still need additional anticoagulation during dialysis 4
  • Monitoring both the venous and arterial air traps is crucial, as clotting occurs more frequently in the venous trap 3

By understanding the differences between clotting and clogging, clinicians can implement appropriate preventive measures and interventions to ensure optimal dialysis efficiency and patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Chapter Title: Management of Coagulation and Thrombosis in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Risk factors of system clotting in heparin-free haemodialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.